AORT

Artivion, Inc.

23.48 USD
-0.33 (-1.39%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Artivion, Inc. stock is up 15.55% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 31 May’s closed higher than April. 100% of analysts rate it a buy.

About Artivion, Inc.

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases.

  • Stifel
    Tue May 7, 08:49
    buy
    confirm
  • Needham
    Tue May 7, 05:54
    buy
    confirm